- September
- 26
Debt Resolve Inc. of White Plains said that it won’t appeal the American Stock Exchange’s decision to suspend trading of the company’s common stock for not meeting listing standards.
Debt Resolve, which runs an online consumer debt settlement service, said it has applied to list the stock on the OTC Bulletin Board.
For now, Debt Resolve said that the stock may trade on the Pink Sheets.
In August, the company said it lost $4.2 million, or 48 cents a share, during the second quarter.
Posted by Jay Loomis on Friday, September 26th, 2008 at 4:37 pm |
Print
|
Email
|
Post a Comment »
- May
- 12
Shares of EpiCept Corp. were higher by a penny a share in afternoon trading today, at 48 cents a share, after reaching a 52-week low of 44 cents a share Friday, following news that the company’s shares face renewed scrutiny by Nasdaq officials.
The Eastview-based biotechnology company said Friday it was notified two days prior that it hadn’t yet regained compliance with a regulation that requires the company’s shares to maintain a market value of $35 million for 10 consecutive trading days.
Last month, Nasdaq officials gave EpiCept until May 5 to regain compliance with the listing requirement.
With last week’s news, EpiCept said it plans to seek a hearing with Nasdaq officials.
EpiCept shares also face delisting for failing to maintain a minimum $1 a share bid price, Nasdaq officials warned the company last month. The company. which is developing treatments for pain and cancer, has until Oct. 13 to regain compliance with minimum-bid price rules.
In the event the company’s shares are delisted, EpiCept said, they may be eligible to trade on the over-the-counter market, an informal method for trading stocks.
Posted by David Schepp on Monday, May 12th, 2008 at 1:18 pm |
Print
|
Email
|
Post a Comment »
